Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M427Revenue (TTM) $M37.6Net Margin (%)-235.9Altman Z-Score0.1
Enterprise Value $M338EPS (TTM) $-1.2Operating Margin %-219.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-235.9Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %-8.4Quick Ratio2.7Cash flow > EarningsY
Price/Sales10.85-y EBITDA Growth Rate %6.0Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-47.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-62.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M77.6ROIC % (ttm)-362.2Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INO is held by these investors:



INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Weiner David B.Director 2017-05-25Sell8,000$8-25.75view
Kim Jong JosephCEO 2017-03-31Sell147,180$6.54-9.17view
COLLINS MORTONDirector 2017-03-27Buy21,300$6.25-4.96view
Sardesai NiranjanCOO 2016-08-29Sell21,800$9.3-36.13view
COLLINS MORTONDirector 2016-06-28Buy10,000$9.13-34.94view
BENITO SIMON XDirector 2016-05-18Sell6,250$10.37-42.72view
COLLINS MORTONDirector 2016-04-15Buy68,400$9.52-37.61view
Sardesai NiranjanCOO 2015-09-30Buy4,000$5.58view
BENITO SIMON XDirector 2015-08-14Buy6,000$7.21-17.61view
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-37.67view

Press Releases about INO :

Quarterly/Annual Reports about INO:

News about INO:

Articles On GuruFocus.com
Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017 Jul 26 2017 
Inovio Announces Pricing of Public Offering of Common Stock Jul 19 2017 
Inovio Announces Proposed Public Offering of Common Stock Jul 18 2017 
Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention Jun 19 2017 
Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cance Jun 08 2017 
Inovio Zika Vaccine Prevents Persistence of Virus and Damage in Male Reproductive Tract in Pre-Clini Jun 07 2017 
Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combinatio Jun 01 2017 
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study May 24 2017 
Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results May 10 2017 
Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head & Neck Cance May 10 2017 

More From Other Websites
Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017 Jul 26 2017
Why MarineMax, Inovio Pharmaceuticals, and Check Point Software Technologies Slumped Today Jul 20 2017
Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : INO-US : July... Jul 20 2017
Biotech Movers: Sarepta, Inovio, Mylan Jul 20 2017
Inovio Announces Pricing of Public Offering of Common Stock Jul 19 2017
Here's Why Inovio Pharmaceuticals, Inc. Stock Fell Today Jul 19 2017
Biotech Movers: Vertex Continues to Move on Data for CF Regimen Jul 19 2017
Wednesday’s Market Insights: DryShips Inc. (DRYS), xG Technology Inc (XGTI), Inovio... Jul 19 2017
Today's Research Reports on Trending Tickers: Inovio Pharmaceuticals Inc. and Universal Display... Jul 19 2017
Inovio Announces Proposed Public Offering of Common Stock Jul 18 2017
Biotech Movers: Exelixis, Omeros, Inovio Jul 10 2017
Inovio’s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation Jul 06 2017
Inovio Announces Leadership Appointments Jun 28 2017
Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention Jun 19 2017
Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues... Jun 15 2017
Why Is Inovio (INO) Up 21.3% Since the Last Earnings Report? Jun 14 2017
3 Stocks That Could Put Amazon's Returns to Shame Jun 13 2017
Cramer’s Exec Cut: CEOs examine the power of strategic pa... Jun 09 2017
Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises Jun 09 2017
Today's Research Reports on Stocks to Watch: Century Aluminum and Inovio Pharmaceuticals Jun 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}